FDA Investigator Lauren N Howard
Lauren N Howard has conducted inspections on 49 sites in 6 countries as of 16 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
49
Last Inspection Date:
16 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada,
Italy,
China,
Germany,
Bulgaria
FDA Investigators that have inspected at least one site in common with Lauren N Howard:
Alan M Barker,
Allison A Aldridge, PhD,
Allison C Hunter,
Amanda M Dunneback,
Andrew J Barrowcliff,
Angela E Glenn,
Anna M Brannen,
Ariel Cruz Figueroa,
Bailey A Uetrecht,
Beatrix D Arevalo,
Beatrix D Hippe,
Bei Y He,
Benjamin D Shuler,
Benjamin J Dastoli,
Bethany L Subel,
Bo Chi, PhD,
Brenda C Hamilton,
Brenda S Zimmer, PhD,
Brian A Roelofs,
Brian D Rogers,
Bruce H Mccullough,
Bryan J Love,
Bryan M Gamble,
Bryce A Hammer,
Byeongtaek Oh,
Camerson E Moore,
Carl A Huffman, III,
Cassandra L Abellard,
CDR Thomas R Berry, PPh,
Charisse K Green,
Charles C Conn, III,
Charles M Edwards,
Cherrie A Zachary,
Cheryl A Grandinetti,
Chiaochun J Wang,
Christina A Miller,
Christina Capacci Daniel, PhD,
Christina L Bigham,
Christopher T Middendorf,
Christopher T Peters,
Claire M Minden,
Colleen E Burke,
Courtney E Hillier,
Craig P Seaborn,
Cynthia T Cain,
D Yvette Barnett,
Dale A Nyberg,
David P Moorhead,
David S Jackson,
Debra I Love,
Debra Lboyd Seale,
Dell S Moller,
Dennis Cantellops Paite,
Dilip Devineni, PhD,
Djamila Harouaka,
Donna F Campbell,
Dr. Carmelo Rosa,
Dr. Zhou Chen (nmi), MD PhD,
Dyvette Arline,
Edwin Martinez,
Elisa A Nickum,
Elisa A Weckerling,
Elizabeth L Loreaux,
Elizabeth Ll Edwards,
Elizabeth P Kinsella,
Eric M Mueller, PharmD,
Frederick M Lochner,
Gam S Zamil,
Genevieve E Ghand,
Geoffrey K Kilili,
Hamet M Toure, PharmD MPH,
Heather A Mccauley,
Hugh M Mcclure, II,
Ian L Mcwilliams,
James Norman,
Javonica F Penn,
Jazmine N Brown,
Jazmine N Still,
Jeanne J Thai,
Jeffrey A Sincek,
Jennifer L Gustavus,
Jesse A Vazquez,
Jill J Tillman,
Jill R Loeliger,
Jill R Raezer,
John A Gonzalez,
Jon P Antoniou,
Jose Acruz Gonzalez,
Joseph A Piechocki,
Joshua P Wireman,
Joshua S Hunt,
Joslyn K Brunelle, PhD,
Kalavati Suvarna, PhD,
Karen M Kondas,
Kathleen D Culver,
Kelli L Wilkinson,
Kenneth E Felkley,
Lauren N Smith,
Laurie Graham,
LCDR Chad N Thompson,
Lequita M Mayhew,
Lianji Jin,
Libia M Lugo,
Lindsey M Schwierjohann,
Lisa Hornback,
Lisa R Hilliar,
Logan T Williams,
Lynnsey A Renn,
Marianne Allen,
Maribeth G Grattan,
Maribeth G Niesen,
Mark E Parmon,
Mary B Sheets,
Massod Rahimi, PhD,
Matt D Suedkamp,
Matthew B Casale,
Matthew H Pitts,
Michael E Clark,
Michael P Sheehan,
Michael Shanks, MS,
Michele L Glendenning,
Michele L Obert,
Michele Perry Williams,
Monica E Murie,
Muna Algharibeh,
Nebil A Oumer,
Nibin Varghese, MS,
Nicholas J Presto,
Nicholas L Paulin,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole S Williams,
Nina Ni,
Noreen Muñiz,
Paranthaman Senthamaraikannan,
Patrick L Wisor,
Phillip M Pontikos,
Rafael Padilla,
Rafeeq A Habeeb,
Richard Ledwidge (nmi), PhD,
Richard T Riggie,
Robbie J Alleman,
Robert J Ham,
Roy C Stephens,
Russell K Riley,
Sandra A Hughes,
Shalonda C Clifford,
Shannon D Fink,
Shannon F Underwood,
Sidney B Priesmeyer,
Stephanie M Mongeluzzi,
Steven C Madzo,
Steven D Kehoe,
Steven P Eastham,
Susan D Yuscius,
Sydney S Choi,
Tamara M Kays,
Tara L Greene,
Tara L King,
Tarun D Mehta,
Ted L Anderson,
Tenzin Jangchup,
Teresa K Kastner,
Thomas J Arista,
Thomas W Nojek,
Tracey L Harris,
Tyler M Peterson,
Tyra S Wisecup,
Ucheabuchi Cchudi Nwankwor,
Vaishali J Patel,
Valerie M Steffens,
Valerie M Toomey,
Veronica Fuentes, MS,
Vipulchandra N Dholakia,
Warren J Lopicka,
Wayne D Mcgrath,
Wen Ning Chan (Sally),
Wendy G Tan, PhD,
Xiaoshi N Wang,
Ying Zhang,
Yiyue Zhang (nmi), PhD,
Yongmin Liu,
Yuanyuan Li,
Yvette Mlacour Davis,
Zhang Zhao, PhD,
Zhigang Sun, PhD
Lauren N Howard's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more